Overview
Today’s scan produced 8 Continuation Breakout signals against a backdrop of a Cautious SA Regime, with breadth sitting at just 51.0% above the 40-day SMA and sentiment reading Very Bearish/Neutral. Average RVOL across the list is modest (roughly 1.1x), which tells us this is not a broad, volume-driven breakout day — it’s a day for selectivity rather than aggression.
Sector-wise, the list skews heavily toward Medical/Health Care (ALNY, FENC, ISRG, SYK — four of eight names), which is encouraging since Health Care is one of today’s top-performing sectors by ATR%. Finance (EFX, LPLA), Insurance (AJG), and Retail (DPZ) round out the diversification. None of the signals originate in the weakest sectors (Real Estate, Industrials, Utilities), which is a modest positive.
Quality Score: 3/5. In a Cautious regime, only the highest-conviction setups deserve top billing — most of today’s candidates show sub-1.0 RVOL and several sit uncomfortably close to supply zones. The demand-zone setups with tight stops and asymmetric reward profiles are where the real edge lies today.
Top 5 Picks
EFX ($194.35) — Finance/Financial Svcs-Specialty
EFX shows the strongest technical signature of the group: an ATR%-M of 3.3 (the highest in this batch), RVOL of 1.1, and price sitting just above a well-defined 1h demand zone at $183.87–$190.38. With supply not appearing until the monthly $201.02–$209.70 zone, EFX offers the cleanest risk/reward setup among today’s candidates, backed by 1,887 institutional funds.
| Level | Price |
|---|---|
| Entry | $194.35 |
| Stop | $183.50 |
| Target 1 | $201.02 |
| Target 2 | $209.70 |
Institutional Backing: 1,887 funds tracked, INST classification.
ISRG ($372.60) — Medical/Medical-Systems
ISRG carries the heaviest institutional footprint on today’s list (4,273 funds) and sits right above a tight 30m demand zone at $364.61–$366.36. While RVOL (0.7) and ATR%-M (-1.0) are soft, the sector tailwind from Health Care and the sheer depth of institutional support make this a lower-volatility, higher-conviction hold with room to $391.67–$398.30 supply.
| Level | Price |
|---|---|
| Entry | $372.60 |
| Stop | $364.00 |
| Target 1 | $391.67 |
| Target 2 | $398.30 |
Institutional Backing: 4,273 funds tracked, INST classification.
AJG ($267.56) — Insurance
AJG posted a 2.9% gain with a healthy ATR%-M of 2.6, holding above its daily demand zone at $257.68–$263.81. Supply sits a comfortable 4.28% away at $279.00–$281.66, giving this setup solid breathing room. Backed by 2,356 institutional funds, this is a steady, lower-drama continuation candidate.
| Level | Price |
|---|---|
| Entry | $267.56 |
| Stop | $257.00 |
| Target 1 | $279.00 |
| Target 2 | $281.66 |
Institutional Backing: 2,356 funds tracked.
ALNY ($237.10) — Medical/Profitable Biotech
ALNY is the asymmetric-reward play of the day: it sits tight against a 1h demand zone at $231.97–$232.84 (only 1.8% away) while daily supply doesn’t appear until $286.62–$290.60 — nearly 21% higher. Momentum is flat (0.2% change, RVOL 0.9) so this requires patience, but the risk/reward skew combined with 2,286 institutional funds makes it worth watching for a demand-zone hold.
| Level | Price |
|---|---|
| Entry | $237.10 |
| Stop | $231.50 |
| Target 1 | $286.62 |
| Target 2 | $290.60 |
Institutional Backing: 2,286 funds tracked.
DPZ ($350.00) — Retail-Restaurants
DPZ is the momentum name of the group, up 5.4% on 1.4x RVOL and pressing into a 4h supply zone at $353.81–$355.24, just 1.09% overhead. A confirmed close above this zone would validate the breakout; the daily demand shelf at $331.05–$339.29 provides the stop reference. Backed by 1,768 institutional funds.
| Level | Price |
|---|---|
| Entry | $355.50 (on breakout confirmation) |
| Stop | $339.29 |
| Target 1 | $360.00 |
| Target 2 | $365.00 |
Institutional Backing: 1,768 funds tracked.
Honorable Mentions
- FENC ($12.27): Highest RVOL (1.9) of the day, but pressing directly into a 30m supply zone just 2.93% away with thin institutional backing (92 funds).
- LPLA ($370.69): Strongest ATR%-M (4.1) but sitting only 1.45% below 1h supply — chasing risk is elevated here.
- SYK ($330.69): Caught “between” zones with flat ATR%-M (0.2); wait for a cleaner demand or supply test before engaging.
Strategy Summary
Today’s continuation setups are respectable but not exceptional — the Cautious regime and sub-1.0 average RVOL warrant a selective approach rather than broad participation. The strongest opportunities cluster around Health Care/Medical names sitting on well-defined demand zones (EFX, ISRG, AJG, ALNY), each offering favorable stop placement below institutional support levels. DPZ stands out as the lone momentum breakout candidate but requires supply-zone confirmation before entry. Overall risk/reward favors patient entries near demand over chasing names pressed against overhead supply.